BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2918950)

  • 1. Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure.
    Yokozawa T; Mo ZL; Oura H
    Nephron; 1989; 51(3):388-92. PubMed ID: 2918950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure.
    Yokozawa T; Oura H; Ienaga K; Nakamura K
    Nephron; 1993; 64(3):424-8. PubMed ID: 8341388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the distribution of methylguanidine with the progression of renal failure after methylguanidine loading.
    Yokozawa T; Fujitsuka N; Oura H
    Nephron; 1989; 52(4):347-51. PubMed ID: 2770951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of creatinine, creatol and methylguanidine on renal function.
    Yokozawa T; Oura H; Ienaga K; Nakamura K
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):973-7. PubMed ID: 1479734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of methylguanidine from creatinine in normal rats and rats with renal failure.
    Yokozawa T; Fujitsuka N; Oura H
    Nephron; 1990; 56(3):249-54. PubMed ID: 2077406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rhubarb tannins on uremic toxins.
    Yokozawa T; Fujioka K; Oura H; Nonaka G; Nishioka I
    Nephron; 1991; 58(2):155-60. PubMed ID: 1865970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the precursor of methylguanidine in rats with renal failure.
    Yokozawa T; Fujitsuka N; Oura H
    Nephron; 1991; 58(1):90-4. PubMed ID: 1857486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study in treating chronic renal failure with dry extract and tannins of herba ephedra].
    Wang GZ; Hikokichi O
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Aug; 14(8):485-8. PubMed ID: 7841758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polyamines, methylguanidine, and guanidinosuccinic acid on calcitriol synthesis.
    Patel S; Hsu CH
    J Lab Clin Med; 1990 Jan; 115(1):69-73. PubMed ID: 2299258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
    Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
    Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure.
    Ando A; Orita Y; Nakata K; Tsubakihara Y; Takamitsu Y; Ueda N; Yanase M; Abe H
    Nephron; 1979; 24(4):161-9. PubMed ID: 492426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
    Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
    Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of (-)-epigallocatechin 3-O-gallate against oxidative stress in rats with adenine-induced renal failure.
    Nakagawa T; Yokozawa T; Sano M; Takeuchi S; Kim M; Minamoto S
    J Agric Food Chem; 2004 Apr; 52(7):2103-7. PubMed ID: 15053559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats.
    Ienaga K; Mikami H; Yokozawa T
    Biol Pharm Bull; 2009 Jul; 32(7):1204-8. PubMed ID: 19571386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic pathway of guanidino compounds in chronic renal failure.
    Mikami H; Orita Y; Ando A; Fujii M; Kikuchi T; Yoshihara K; Okada A; Abe H
    Adv Exp Med Biol; 1982; 153():449-58. PubMed ID: 7164918
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
    Sawynok J; Dawborn JK
    Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.